Published in Cardiovascular Business Week, June 30th, 2009
The three trials ranged in duration from 8 to 12 weeks and collected clinical data on more than 460...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.